Idioma:

Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi

Olivares-Illana, Vanesa ; Rodríguez-Romero, Adela ; Becker, Ingeborg ; Berzunza, Miriam ; García, Juventino ; Pérez-Montfort, Ruy ; Cabrera, Nallely ; López-Calahorra, Francisco ; de Gómez-Puyou, Marieta Tuena ; Gómez-Puyou, Armando Dalton, John

PLoS neglected tropical diseases, 2007-10, Vol.1 (1), p.e1 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por

Enviar para

Título:
Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi
Autor: Olivares-Illana, Vanesa ; Rodríguez-Romero, Adela ; Becker, Ingeborg ; Berzunza, Miriam ; García, Juventino ; Pérez-Montfort, Ruy ; Cabrera, Nallely ; López-Calahorra, Francisco ; de Gómez-Puyou, Marieta Tuena ; Gómez-Puyou, Armando
Dalton, John
Assuntos: Aniline Compounds - pharmacology ; Animals ; Biochemistry ; Biochemistry/Biocatalysis ; Biochemistry/Biomacromolecule-Ligand Interactions ; Biochemistry/Drug Discovery ; Biochemistry/Experimental Biophysical Methods ; Biochemistry/Protein Chemistry ; Chagas Disease - drug therapy ; Chagas Disease - epidemiology ; Chagas' disease ; Cysteine - analysis ; Dimerization ; Enzymes ; Escherichia coli - enzymology ; Escherichia coli - genetics ; Humans ; Incidence ; Infectious Diseases/Neglected Tropical Diseases ; Infectious Diseases/Protozoal Infections ; Kinetics ; Malaltia de Chagas ; Microbiology/Parasitology ; Models, Molecular ; Parasites ; Protein Conformation ; Proteins ; Recombinant Proteins - drug effects ; Sequence Deletion ; Triose-Phosphate Isomerase - chemistry ; Triose-Phosphate Isomerase - genetics ; Triose-Phosphate Isomerase - metabolism ; Trypanosoma cruzi - drug effects ; Trypanosoma cruzi - enzymology ; Trypanosoma cruzi - growth & development ; X-Ray Diffraction
É parte de: PLoS neglected tropical diseases, 2007-10, Vol.1 (1), p.e1
Notas: Conceived and designed the experiments: AG VO IB RP MT. Performed the experiments: VO MB NC. Analyzed the data: AG VO AR. Contributed reagents/materials/analysis tools: JG FL. Wrote the paper: AG AR IB JG RP FL MT. Synthesized the compounds used: VO. Performed the experiments with E. coli: NC. Performed the experiments with the parasites: MB. Crystallized the enzyme and analyzed the X-ray data: ARR. Planned the experiments with the parasites: IB. Planned, synthesized and identified the compounds used: JG FLC. Planned and supervised the experiments: MTdGP RPM AGP.
Descrição: Chagas disease affects around 18 million people in the American continent. Unfortunately, there is no satisfactory treatment for the disease. The drugs currently used are not specific and exert serious toxic effects. Thus, there is an urgent need for drugs that are effective. Looking for molecules to eliminate the parasite, we have targeted a central enzyme of the glycolytic pathway: triosephosphate isomerase (TIM). The homodimeric enzyme is catalytically active only as a dimer. Because there are significant differences in the interface of the enzymes from the parasite and humans, we searched for small molecules that specifically disrupt contact between the two subunits of the enzyme from Trypanosoma cruzi but not those of TIM from Homo sapiens (HTIM), and tested if they kill the parasite. Dithiodianiline (DTDA) at nanomolar concentrations completely inactivates recombinant TIM of T. cruzi (TcTIM). It also inactivated HTIM, but at concentrations around 400 times higher. DTDA was also tested on four TcTIM mutants with each of its four cysteines replaced with either valine or alanine. The sensitivity of the mutants to DTDA was markedly similar to that of the wild type. The crystal structure of the TcTIM soaked in DTDA at 2.15 A resolution, and the data on the mutants showed that inactivation resulted from alterations of the dimer interface. DTDA also prevented the growth of Escherichia coli cells transformed with TcTIM, had no effect on normal E. coli, and also killed T. cruzi epimastigotes in culture. By targeting on the dimer interface of oligomeric enzymes from parasites, it is possible to discover small molecules that selectively thwart the life of the parasite. Also, the conformational changes that DTDA induces in the dimer interface of the trypanosomal enzyme are unique and identify a region of the interface that could be targeted for drug discovery.
Editor: United States: Public Library of Science
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi

Olivares-Illana, Vanesa ; Rodríguez-Romero, Adela ; Becker, Ingeborg ; Berzunza, Miriam ; García, Juventino ; Pérez-Montfort, Ruy ; Cabrera, Nallely ; López-Calahorra, Francisco ; de Gómez-Puyou, Marieta Tuena ; Gómez-Puyou, Armando Dalton, John

United States: Public Library of Science

Buscando em bases de dados remotas. Favor aguardar.